Chronic Myelogenous Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies - 2022
Completed
  • Acute Lymphoblastic Leukemia
  • +5 more
  • Radiation
  • +3 more
  • New Hyde Park, New York
    Cohen Children's Medical Center
2022-04-06
Apr 6, 2022
N
Reduced Intensity Conditioning Transplant Using Haploidentical Donors - 2020
Completed
  • Chronic Myelogenous Leukemia
  • +9 more
  • Atlanta, Georgia
    Northside Hospital
2022-04-04
Apr 4, 2022
N
Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy - 2022
Completed
  • Acute Myelogenous Leukemia
  • +6 more
  • This is a non-interventional study
  • Bakersfield, California
  • +19 more
2022-04-04
Apr 4, 2022
N
Specialized Blood Cell Transplants for Cancers of the Blood and Bone Marrow - 2020
Completed
  • Myeloproliferative Disorders
  • +4 more
  • T-cell replete PBPC allograft
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-03-24
Mar 24, 2022
N
Study of Efficacy of CML-CP Patients Treated With ABL001 Versus Bosutinib, Previously Treated With 2 or More TKIs
Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
2022-03-21
Mar 21, 2022
C
Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies
Active, not recruiting
  • Acute Lymphoblastic Leukemia/Lymphoma
  • +4 more
    • Scottsdale, Arizona
    • +31 more
    2022-03-08
    Mar 8, 2022
    W
    Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
    Active, not recruiting
    Has Results
    • Acute Myelogenous Leukemia
    • +10 more
    • Atlanta, Georgia
    • +2 more
    2022-02-09
    Feb 9, 2022
    C
    HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
    Recruiting
    • Acute Lymphoblastic Leukemia
    • +7 more
    • Duarte, California
    • +16 more
    2022-02-25
    Feb 25, 2022
    H
    PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation
    Active, not recruiting
    • Myeloid Malignancies
    • +4 more
    • Fludarabine and Busulfan plus/minus Total Body Irradiation (low dose)
    • Fludarabine and Busulfan + Low Dose Total Body Irradiation (LD TBI)
    • Hackensack, New Jersey
      John Theurer Cancer Center at Hackensack University Medical Cent
    2022-02-25
    Feb 25, 2022
    B
    CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
    Not yet recruiting
    • Hematologic Diseases
    • +5 more
    • CliniMACS
    • +7 more
    • Miami, Florida
      Miami Cancer Institute at Baptist Health, Inc.
    2022-02-21
    Feb 21, 2022
    N
    Asciminib Treatment Optimization in ≥ 3rd Line CML-CP.
    Recruiting
    • Chronic Myelogenous Leukemia
    • ABL001 40mg BID
    • +2 more
    • Linz, Austria
    • +24 more
    2022-02-17
    Feb 17, 2022
    A
    Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia
    Recruiting
    • Chronic Myelogenous Leukemia
    • Beirut, Lebanon
      American University of Beirut Medical Center
    2022-02-14
    Feb 14, 2022
    M
    Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
    Recruiting
    • Chronic Myelogenous Leukemia
    • Chart Review
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    2022-02-08
    Feb 8, 2022
    N
    Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP)
    Active, not recruiting
    • CML
    • +3 more
    • Asciminib add-on
    • +2 more
    • Augusta, Georgia
    • +29 more
    2022-02-03
    Feb 3, 2022
    H
    Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
    Recruiting
    • Acute Myeloid Leukemia
    • +17 more
    • Tampa, Florida
      H. Lee Moffitt Cancer Center & Research Institute
    2022-01-26
    Jan 26, 2022
    H
    Low Dose Dasatinib (50 mg Daily) as First-line Treatment for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Amman, Jordan
    • +4 more
    2022-01-17
    Jan 17, 2022
    N
    A Phase I Study of Oral ABL001 in Patients With CML or Ph+ ALL
    Active, not recruiting
    • Chronic Myelogenous Leukemia
    • Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
    • Boston, Massachusetts
    • +18 more
    2022-01-10
    Jan 10, 2022
    V
    Allogeneic Stem Cell Transplantationin Relapsed Hematological Malignancy: Early GVHD Prophylaxis
    Active, not recruiting
    • Hodgkin's Lymphoma
    • +17 more
    • mycophenolate mofetil
    • +2 more
    • Richmond, Virginia
      Virginia Commonwealth University/Massey Cancer Center
    2021-12-21
    Dec 21, 2021
    N
    Asciminib Roll-over Study
    Not yet recruiting
    • Chronic Myelogenous Leukemia
    • Asciminib single agent
    • +6 more
    • (no location specified)
    2021-11-25
    Nov 25, 2021
    W
    The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
    Recruiting
    • Acute Myelogenous Leukemia
    • +9 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Health
      2021-11-23
      Nov 23, 2021
      H
      Cognitive Behavioral Intervention for Targeted Therapy Fatigue (CBT-TTF) Intervention - 2021
      Completed
      Has Results
      • Chronic Myelogenous Leukemia
      • Therapy for Targeted Therapy-related Fatigue (TTF)
      • Wait-List Control Condition (WLC)
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      2021-11-15
      Nov 15, 2021
      N
      Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
      Active, not recruiting
      Has Results
      • Chronic Myelogenous Leukemia
      • Nilotinib followed by treatment-free
      • Fort Myers, Florida
      • +113 more
      2021-11-11
      Nov 11, 2021
      M
      UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep
      Recruiting
      • Acute Leukemia
      • +24 more
      • Minneapolis, Minnesota
        Masonic Cancer Center at University of Minnesota
      2021-11-04
      Nov 4, 2021
      S
      Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft
      Recruiting
      • Allogeneic Hematopoietic Cell Transplantation (HCT)
      • +5 more
      • Purified regulatory T-cells (Treg) plus CD34+ HSPC
      • +7 more
      • Stanford, California
        Stanford University
      2021-10-28
      Oct 28, 2021
      M
      Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) - 2014
      Completed
      Has Results
      • Acute Myelogenous Leukemia
      • +4 more
      • Single Umbilical Cord Blood Unit Transplant
      • +6 more
      • Birmingham, Alabama
      • +37 more
      2021-10-13
      Oct 13, 2021